National Health Investors (NHI) Earnings Analysis

National Health Investors (NHI) next reports earnings on 2026-08-10, consensus EPS 0.868 USD. Last quarter (2026-05-04) it missed with EPS 0.83 USD vs 1.21 USD est (-31.4%). It has beaten estimates in 2/3 recent quarters (67%). Trailing P/E 25.72.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does NHI next report earnings?

Next earnings date2026-08-10
Consensus EPS estimate0.868 USD
Revenue estimate0.07B

NHI earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-040.83 USD1.21 USD-31.4%Miss
2026-02-261.22 USD0.801 USD+52.3%Beat
2025-05-051.15 USD1.13 USD+1.8%Beat

Beat rate: 2/3 (67%) over reported quarters with consensus data.

NHI valuation and analyst view

Trailing P/E25.72
Trailing EPS3.065 USD
Price / book2.55
Dividend yield4.60%
Market cap3.88B
Analyst consensusHold (6 buy / 12 hold / 1 sell)
Avg price target80.33 USD

Related research pages

Frequently asked questions

When is National Health Investors (NHI)'s next earnings date?

National Health Investors is next scheduled to report on 2026-08-10, with a consensus EPS estimate of 0.868 USD and revenue estimate of 0.07B.

Did NHI beat earnings last quarter?

In its 2026-05-04 report, NHI posted EPS of 0.83 USD versus a 1.21 USD estimate — a miss of 31.4%.

What is NHI's earnings track record?

Over the last 3 reported quarters with consensus data, NHI beat estimates 2 times (67%).

What is NHI's current P/E ratio and EPS?

NHI trades at a trailing P/E of 25.72 on trailing EPS of 3.065022940490475 USD.

What do analysts rate NHI?

Analyst consensus is "Hold" across 19 ratings (0 strong buy, 6 buy, 12 hold, 1 sell, 0 strong sell). Average 12-month price target: 80.33 USD.